| N |
|
National Resource for Infection Control (www.nric.org.uk): meeting a need?
|
| Wiseman S., Kostkova P., Hansraj F. |
| |
|
Nationwide increase of invasive ampicillin resistant Enterococcus faecium in the Netherlands
|
| Top J., Willems R., van der Velden S., Asbroek M., Bonten M. |
| |
|
Natural coumarins from the plants Seseli devenyense and Peucedanum luxurians as in vitro antibacterial agents
|
| Widelski J., Craikou K., Glowniak K., Chinou E., Chinou I. |
| |
|
Natural variation within Staphylococcus aureus populations determines concentration and time-dependent phenotypic daptomycin resistance
|
| Morosini M., García-Castillo M., Cantón R., Levin B., Baquero F. |
| |
|
Negative correlation between biofilm formation and antibiotic sensitivity in clinical isolates of clonally related Acinetobacter baumannii
|
| Fugazza G., Landini P., Migliavacca R., Spalla M., Nucleo E., Navarra A., Daturi R., Pagani L. |
| |
|
Neoplasia in patients with HIV infection: effect of HAART
|
| Garcia-Egido A.A., Escobar M.A., Romero S.P., Bernal J.A., Asencio C., Puerto J.L., Gonzalez-Outon J., Gomez F. |
| |
|
Neuroborreliosis and tick-borne encephalitis same vector, but different clinical course
|
| Soltysova K., Smiskova D., Picha D., Sojkova N., Podojilova M., Roubalova K., Sedivy K., Maresova V. |
| |
|
New antiprotozoal drugs refered as antimicrotubular haloacetamidobenzoates
|
| Fellous A., Valentin A., Andrade S., Kalil J., Veauvy M., Le Borgne M., Le Pape P. |
| |
|
New concerns with human brucellosis in France in the beginning of the 3rd millenium
|
| Mailles A., Garin-Bastuji B., Maurin M., Vaillant V. |
| |
|
New emerging human infection caused by Bartonella vinsonii ssp. arupensis in Russia
|
| Kruglov A., Barmina G., Osadchaya V., Frolova G., Markov A., Smirnov G., Bashkirov V., Kirillov M., Kosoy M. |
| |
|
New enzyme immunoassay ``DS-EIA-HIV-AG-SCREEN'' for early diagnostics of HIV infection
|
| Sharipova I., Baranova E., Levina M., Burkov A., Oriadina A., Ulanova T. |
| |
|
New immunometric concept for rapid MRSA screening without pure-culture
|
| Koskinen J., Stenholm T., Vaarno J., Soini A. |
| |
|
New perspectives on the bacteriology and antimicrobial susceptibility of dog bite wounds
|
| Meyers B., Schoeman J., Goddard A., Seakemela E., Picard J. |
| |
|
New targets for innovative HIV treatment
|
| Fätkenheuer G. |
| |
|
New VIM-2-like metallo-b-lactamases in Pseudomonas aeruginosa from Germany and Bulgaria
|
| Schneider I., Keuleyan E., Rasshofer R., Bauernfeind A. |
| |
|
Nineteen cases of Actinobaculum schaalii identified in Viborg County, Denmark
|
| Jakobsen T.F., Nielsen H.L., Søby K.M., Prag J. |
| |
|
No evidence for hypoadrenalism as a cause of early mortality in a high HIV/TB prevalence population starting anti-tuberculosis treatment in Malawi
|
| Beadsworth M.B.J., van Oosterhout J.J., Diver M., Shenkin A., Mwandumba H.C., Khoo S., O'Dempsey T., Squire S.B., Zijlstra E.E. |
| |
|
No re-imbursement for statins, fibrates, and omega-3 derivatives for HIV-infected patients with HAART-related dyslipidaemia in Italy
|
| Manfredi R., Calza L. |
| |
|
Nocardiosis as an unexpected complication of end-stage, untreated HIV disease
|
| Manfredi R. |
| |
|
Non-tuberculous mycobacteria in a Spanish teaching hospital during a five-year period
|
| Domingo D., Carracedo R., Fillol R., Alarcon T., Moreno M., Agudo S., Lopez-Brea M. |
| |
|
Nosocomial endocarditis due to Gram-negative bacteria
|
| Demitrovicova A., Findova L., Krcmery V., Hricak V., Karvaj M. |
| |
|
Nosocomial invasive pneumococcal disease in Toronto, Canada, 19952005
|
| Green K., Low D., McGeer A. |
| |
|
Nosocomial meningitis
|
| Garcia-Cabrera E., Jiménez-Mejías M.E., Serra-Vich J., Pintado V., Grill F., Portillo M., Colomina J., Prats G., Pachón-Diaz J. |
| |
|
Nosocomial meningitis in the NICU population: perinatal risk factors, aetiology and outcome
|
| Behrendt J., Stojewska M., Wasek-Buko M., Krolak-Olejnik B., Godula-Stuglik U. |
| |
|
Nosocomial outbreak of Sphingomonas paucimobilis bacteraemia in an oncology and haematology unit
|
| Kilic A., Senses Z., Kurekci A., Aydogan H., Basustaoglu A.C. |
| |
|
Nosocomial outbreak of telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in a Japanese hospital
|
| Muratani T., Kobayashi T., Matsumoto on behalf of the Hibiki Research Group for Clinical Microbiology T. |
| |
|
Nosocomial outbreak of vancomycin-resistant Enterococcus faecium at a Turkish University Hospital
|
| Ozcan A., Ozhak Baysan B., Ogunc D., Inan D., Naas T., Colak D., Nordmann P. |
| |
|
Nosocomial urinary tract infections in urology sections. Data from the PEP and PEAP-studies
|
| Bjerklund Johansen T., Cek M., Naber K., Grabe M., Tenke on behalf of the European Society for Infection in Urology P. |
| |
|
Novel acyclic substituted (pyridin-3-yl)phenyl oxazolidinones: antibacterial agents with reduced activity against monoamine oxidase A and improved solubility
|
| Reck F., Zhou F., Zainoun G., Carcanague D., Eyermann C., Gravestock M. |
| |
|
Novel insights into the molecular diagnostics and epidemiology of C. difficile
|
| Rupnik M. |
| |
|
Novel small-molecule inhibitors of gyrase B: antibacterial activity in vitro and in murine models of infection
|
| Haydon D., Lancett P., Bennett J., Czaplewski L. |
| |